Solas BioVentures leads funding round for InterShunt Technologies

InterShunt Technologies, Inc., an early-stage medical device company, has raised an undisclosed amount of funding.

InterShunt Technologies, Inc., an early-stage medical device company, has raised an undisclosed amount of funding. Solas BioVentures led the round with participation from other investors that included Arsenal Capital Management.

Source: Press Release